WHO ICTRP trial
Phase 3 placebo controlled study of cetirizine dry syrup in children suffering…
JPRN-jRCT2080220408 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080220408 |
|---|---|
| Public title | Phase 3 placebo controlled study of cetirizine dry syrup in children suffering from perennial allergic rhinitis ( Comparative study) |
| Scientific title | Phase 3 placebo controlled study of cetirizine dry syrup in children suffering from perennial allergic rhinitis ( Comparative study) |
| Primary sponsor | GlaxoSmithKline K.K. |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 3 |
| Conditions | Perennial allergic rhinitis |
| Interventions | investigational material(s) Generic name etc : Cetirizine INN of investigational material : Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational material : Oral |
| Registration date | Jun 21, 2007 |
| Target size | 236 |
| Secondary IDs | JapicCTI-070417 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: